Regulatory Updates
🇺🇸 FDA Page 31FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 361–372 of 373 articles
FDA Approves VitaRestore: New Treatment for Age-Related Macular Degeneration
FDA · Age-Related Macular Degeneration · 6 min
Dr. Sarah MitchellFDA Approves NasoClear: First Nasal Spray for Pediatric RSV
FDA · Pediatric Infectious Diseases · 6 min
Dr. Sarah MitchellFDA Approves Revitalize: Breakthrough for Chronic Fatigue Syndrome
FDA · Chronic Fatigue Syndrome · 6 min
Dr. Sarah MitchellBlockchain in Pharmaceutical Supply Chain: Ensuring Drug Safety with FDA Insights
FDA · 10 min
Dr. Sarah MitchellFDA Approves Dupixent for Eosinophilic Esophagitis Treatment
FDA · Eosinophilic Esophagitis · 4 min
Dr. Sarah MitchellFDA Approves Stelara: New Ulcerative Colitis Treatment from J&J
FDA · Ulcerative Colitis · 4 min
Dr. Sarah MitchellFDA Approves Trikafta for Cystic Fibrosis in Children Ages 2-5
FDA · cystic fibrosis · 4 min
Dr. Sarah MitchellFDA Approves RapidClot: Tranexamic Acid for Trauma Bleeding
FDA · Trauma Hemorrhage Management · 4 min
Dr. Sarah MitchellFDA Approves Repatha for Pediatric Heterozygous Familial Hypercholesterolemia
FDA · cardiology · 4 min
Dr. Sarah MitchellFDA Approves Adzynma: New Treatment for Thrombotic Thrombocytopenic Purpura
FDA · Hematology · 6 min
Dr. Sarah MitchellFDA Approves Veozah: New Non-Hormonal Menopause Treatment
FDA · Menopause · 4 min
Dr. Sarah MitchellCAR-T Cell Therapy Advancements and FDA Regulatory Pathways 2024
FDA · Hematologic Malignancies · 10 min
Dr. Sarah MitchellExplore intelligence